Last reviewed · How we verify
NCT06807827: COGNIPHARM-II
Pharmacist-Led Cognitive Behavioral Intervention for Diabetic Patients: a Randomized Interventional Trial to Evaluate the Impact on Medication Adherence and Quality of Life
NA trial testing Pharmacist-led Cognitive Behavioral therapy in Diabete Mellitus in 385 participants. Not yet recruiting.
30 July 2025
Quick facts
| Lead sponsor | Hamdard University |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | supportive care |
| Enrollment | 385 |
| Start date | 20 February 2025 |
| Primary completion | 30 July 2025 |
| Estimated completion | 31 August 2025 |
| Sites | 1 location across Pakistan |
Drugs / interventions tested
- Pharmacist-led Cognitive Behavioral therapy
- Basic Education
Conditions studied
- Diabete Mellitus — all drugs for Diabete Mellitus →
Sponsor
Hamdard University
Who can join
Adults 25 to 70, any sex, with Diabete Mellitus. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This interventional study will to assess the impact of pharmacist-led educational intervention along with cognitive behavioral intervention in diabetic patients. Participants of this study will be provided regular counselling or cognitive behavioral intervention and educational material as part of their routine pharmacy visit. Researchers will compare the two groups to see which of the two groups improve in term of medication adherence and quality of life.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06807827
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Pharmacist-led Cognitive Behavioral therapy
Trials testing the same drug.
- NCT06034353 — Impact of Pharmacist-led Cognitive Behavioral Intervention on Adherence and Quality of Life of Epileptic Patients · NA · completed
Other recruiting trials for Diabete Mellitus
Currently open trials in the same condition.
- NCT07378956 — Clinical Efficacy of Implementing an AI-SaMD for Funduscopy Analysis in Patients With Diabetes Mellitus · NA · recruiting
- NCT07432893 — Assessing the Effectiveness of Large Language Model (LLM)-Enabled Nurse Treatment Planning in 2 Indian Districts · NA · recruiting
- NCT07486050 — The Impact of Social Worker Referrals on Diabetes and Loneliness · NA · active not recruiting
- NCT07293156 — Impact of Pilates Exercises on Diabetic Erectile Dysfunction. · NA · recruiting
- NCT07496593 — Total Intravenous and Balanced Anesthesia in Diabetic Patients Undergoing Video-Assisted Thoracoscopy · Phase 4 · active not recruiting
Other Hamdard University trials
Trials by the same sponsor.
- NCT06863285 — Asthma Control Through Telemedicine · NA · not yet recruiting
- NCT06841497 — Safety and Efficacy Assessment of Unani Formulation 'Dolabi' in Management of Diabetes Mellitus Type II · NA · active not recruiting
- NCT06826248 — Clinical Efficacy of Darqeen Capsule for the Management of Hypothyroidism Associated with Female Reproductive Hormonal I · EARLY_PHASE1 · active not recruiting
- NCT07279909 — Phase-III Clinical Studies on Poly Herbal Anti-Diabetic Formulation · Phase 3 · active not recruiting
- NCT06034353 — Impact of Pharmacist-led Cognitive Behavioral Intervention on Adherence and Quality of Life of Epileptic Patients · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06807827 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hamdard University
- Last refreshed: 4 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06807827.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing